Streetbeat News

Stock Prices

LLY

Eli Lilly and Company (NYSE:LLY) plans to acquire Versanis Bio, a cardiometabolic diseases drug manufacturer, for up to $1.925 billion in cash. The acquisition will strengthen Eli Lilly's product profile of obesity-curbing drugs. Versanis' bimagrumab drug, which reduces fat mass while preserving muscle mass, is currently being assessed in a Phase 2b study. Eli Lilly's shares are trading higher by 2.58% to $445.90.

Portfolio Pulse from Nabaparna Bhattacharya

July 14, 2023 | 2:17 pm

DFLI

PRFX

PTPI

RIVN

RXRX

Benzinga's Stock Whisper Index highlights five stocks that warrant attention. This week's stocks include Rivian Automotive (RIVN), which saw a 70% rise in shares due to strong Q2 production and delivery numbers; Recursion Pharmaceuticals (RXRX), which announced a $50 million investment by Nvidia Corporation (NVDA); Dragonfly Energy Holdings Corp (DFLI), which saw a small rally after announcing that nuCamp RV will use its products as standard equipment; Petros Pharmaceuticals (PTPI), which recently announced a $15 million private placement; and PainReform (PRFX), which saw a 40% rise in shares year-to-date.

Portfolio Pulse from Chris Katje

July 14, 2023 | 2:17 pm

SCHW

A significant amount of bearish options activity has been detected for Charles Schwab (NYSE:SCHW), with 66% of investors opening trades with bearish expectations. The targeted price range for Charles Schwab over the last 3 months is $55.0 to $65.0. The current price of SCHW is $59.9, down -0.05%. RSI indicators suggest the stock may be overbought. Next earnings are expected in 4 days. Analysts' price targets range from $60 to $73.

Portfolio Pulse from Benzinga Insights

July 14, 2023 | 2:16 pm

HUM

A significant bullish stance has been taken on Humana (NYSE:HUM) by a large investor, as indicated by a large position in the company's options. The overall sentiment of these big-money traders is split between 68% bullish and 31% bearish. The price target for Humana over the last 3 months has been between $420.0 to $465.0. Wells Fargo and Mizuho have maintained their Overweight and Buy ratings on Humana respectively, while RBC Capital and JP Morgan have downgraded their actions.

Portfolio Pulse from Benzinga Insights

July 14, 2023 | 2:16 pm

ADBE

A significant bearish stance has been taken on Adobe (NASDAQ:ADBE) by a large investor, as indicated by a large position in options. The sentiment among these big-money traders is 26% bullish and 73% bearish. The whales have been targeting a price range from $360.0 to $620.0 for Adobe over the last 3 months. Adobe's current price is $520.57, up 0.64%. Analysts from Goldman Sachs, Piper Sandler, BMO Capital, Mizuho, and RBC Capital have maintained their ratings on Adobe, with price targets ranging from $520 to $572.

Portfolio Pulse from Benzinga Insights

July 14, 2023 | 2:16 pm

WFC

Wells Fargo has announced plans to repurchase more of its stock this year, but will maintain significant capital until there is more clarity on new capital requirements.

Portfolio Pulse from Happy Mohamed

July 14, 2023 | 2:16 pm

SGMT

Sagimet Biosciences has priced its IPO at $16 per share, with 5.3125 million shares being offered. However, the IPO is indicating $17.50 on 87,000 shares.

Portfolio Pulse from Happy Mohamed

July 14, 2023 | 2:15 pm

NETD

Nabors Energy Transition Corp. II has indicated an initial public offering (IPO) price of $10.10 on 1.7 million shares.

Portfolio Pulse from Happy Mohamed

July 14, 2023 | 2:14 pm

APGE

Apogee Therapeutics has priced its IPO at $17 per share, with 17.65 million shares being offered. The IPO is currently indicating $22.10 on 266K shares.

Portfolio Pulse from Happy Mohamed

July 14, 2023 | 2:13 pm

AIMD

BTB

EDTX

JPM

LESL

PRFX

THRX

US stocks traded higher with the Dow Jones gaining over 150 points. JPMorgan Chase & Co. reported better-than-expected Q2 financial results with net revenue of $42.4 billion, up 34.1% YoY. PainReform Ltd., Ainos, Inc., and EdtechX Holdings Acquisition Corp. II saw significant stock price increases. Theseus Pharmaceuticals, Inc., Bit Brother Limited, and Leslie's, Inc. saw significant stock price decreases.

Portfolio Pulse from Lisa Levin

July 14, 2023 | 2:12 pm